Litigation

Recent Posts

High Court: Reverse-Payment Settlements Are Not Immune From Antitrust Scrutiny
Posted on 17 Jun 2013 by Joan Grossman

WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on June 17 ruled 5-3 that reverse-payment settlements of patent litigation between the holder of a drug patent and potential generic manufacturers of the drug are not necessarily immunized from... Read More

Tags: Solvay Pharmaceuticals Inc. Actavis Inc. , reverse-payment settlements , Antitrust , Paddock Holdings Inc. , Par Pharmaceutical Cos. Inc. , patent litigation , 11th Circuit U.S. Court of Appeals , Litigation , Federal Trade Commission v. Actavis , Federal Trade Commission , U.S. Supreme Court , Watson Pharmaceuticals Inc.

11th Circuit Affirms Exclusion Of Plaintiff Expert In First Seroquel Bellwether
Posted on 7 Apr 2010 by Tom Moylan

ATLANTA — (Mealey’s) The sole causation expert for the first bellwether plaintiff in the Seroquel multidistrict litigation failed to rule out other causes of weight gain and diabetes, a panel of the 11th Circuit U.S. Court of Appeals said... Read More

Tags: Linda Guinn v. AstraZeneca Pharmaceuticals LP , Daubert v. Merrill Dow Pharmaceuticals , emerging drugs & devices , expert admissibility , 11th Circuit U.S. Court of Appeals , Litigation , Liknda Guinn , AstraZeneca Pharmaceuticals , Daubert , torts , Seroquel